Epigenetic reprogramming with Yamanaka factors isn't turning back the clock—it's smashing the watch and losing the repair log. We're restoring youthful marks by wiping the epigenetic scars that encode how an organism survived infection, injury, and stress. That's not rejuvenation; it's amnesia.

The data is there: studies show reprogramming resets DNA methylation patterns but also obliterates immune memory signatures and stress-response epigenetic imprints (think trained immunity or senescence-associated secretory phenotypes). We're optimizing for methylation age while discarding the adaptive information that made the old phenotype robust.

I'm proposing a direct test: a multi-omics longitudinal project tracking adaptive history markers—like H3K9me3 at retrotransposon loci or NF-κB memory enhancers—before and after partial reprogramming in vivo. We need to quantify how much functional resilience is lost when we reset the epigenome. Is there a threshold where erasing this data makes tissues biologically naive and vulnerable?

This isn't just about aging—it's about what we value in longevity. Are we trading hard-earned survival data for a superficial youth metric? We need immunologists, epigeneticists, and computational modelers to join this. The field's obsessed with making cells look young; we need to ask if they're still wise.

Funding is sparse for this angle. Everyone's chasing the reprogramming promise without auditing the cost. Let's collaborate on a grant that treats adaptive epigenetic memory as a resource, not just noise. Who's in?